Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Global Health, University of Washington, Seattle, WA, USA.
AIDS Care. 2021 Jun;33(6):712-720. doi: 10.1080/09540121.2020.1822505. Epub 2020 Sep 21.
The Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) Initiative aims to reduce HIV infections among adolescent girls and young women (AGYW) in Africa. Oral pre-exposure prophylaxis (PrEP) is offered through DREAMS in Kenya to eligible AGYW in high burden counties including Kisumu and Homa Bay. This study examines PrEP persistence among AGYW in high burden community-based PrEP delivery settings. We evaluated PrEP persistence among AGYW in the DREAMS PrEP program in Kisumu and Homa Bay using survival analysis and programmatic PrEP refill data collected between March through December 2017. Among 1,259 AGYW who initiated PrEP during the study period, the median persistence time in the program was 56 days (95% CI: 49-58 days) and the proportion who persisted 3 months later was 37% (95% CI: 34-40%). Persistence varied by county ( < 0.001), age at PrEP initiation ( = 0.002), marital status ( = 0.008), transactional sex ( = 0.002), gender-based violence (GBV) experience ( = 0.009) and current school attendance ( = 0.001) at DREAMS enrollment. Persistence did not vary with orphan status, food insecurity, condom use, age at first sexual encounter or engagement in age-disparate sex at DREAMS enrollment. Targeted strategies are needed to improve AGYW retention in the PrEP program.
DREAMS 倡议旨在减少非洲青少年女孩和年轻妇女(AGYW)中的艾滋病毒感染。肯尼亚的 DREAMS 通过口服暴露前预防(PrEP)为符合条件的高危县(包括基苏木和霍马贝)的 AGYW 提供 PrEP。本研究考察了在高负担社区提供 PrEP 的背景下,AGYW 中 PrEP 的持续性。我们使用生存分析和 2017 年 3 月至 12 月期间收集的计划 PrEP 补充数据,评估了基苏木和霍马贝 DREAMS PrEP 计划中 AGYW 的 PrEP 持续性。在研究期间开始接受 PrEP 的 1259 名 AGYW 中,该方案的中位持续时间为 56 天(95%CI:49-58 天),3 个月后持续的比例为 37%(95%CI:34-40%)。持续性因县而异(<0.001),PrEP 开始时的年龄(=0.002),婚姻状况(=0.008),交易性性行为(=0.002),性别暴力(GBV)经历(=0.009)和 DREAMS 登记时的当前学校出勤率(=0.001)。在 DREAMS 登记时,孤儿状态、粮食不安全、避孕套使用、首次性行为年龄或从事年龄差异性行为与持续性无关。需要采取有针对性的策略来提高 PrEP 方案中 AGYW 的保留率。
PLOS Glob Public Health. 2025-4-28
Ther Adv Infect Dis. 2024-12-7
J Acquir Immune Defic Syndr. 2025-4-1
Curr HIV/AIDS Rep. 2019-4